TürkçePleural effusion is a clinical condition characterized by the accumulation of excess fluid within the pleural space surrounding the lungs. This condition restricts lung expansion, impairs respiratory function, and, depending on the underlying disease, may lead to mild or severe respiratory failure.
Symptoms of pleural effusion include shortness of breath, chest pain, dry cough, and exertional breathing difficulty. Physical examination may reveal diminished breath sounds. The diagnosis is confirmed using imaging methods such as chest X-ray, ultrasonography, and computed tomography.
The causes of pleural effusion include systemic or localized diseases such as heart failure, pneumonia, tuberculosis, malignancies, and pulmonary embolism. Biochemical analysis of the pleural fluid plays a critical role in distinguishing between transudative and exudative effusions and identifying the underlying pathology.
Treatment of pleural effusion is planned according to the underlying cause, and thoracentesis may be performed to drain the fluid when necessary. Antibiotic therapy is preferred in infection-related cases, while drainage procedures and pleurodesis may be used for malignant effusions. Early intervention improves prognosis.
In Which Area Does Pleural Effusion (Pleurisy) Occur?
In a healthy human body, the lungs are in constant motion within the bony and muscular structure known as the rib cage. Every time a person inhales, the lungs expand like a balloon, and they contract during exhalation. To prevent this continuous movement from causing friction against the rigid inner walls of the chest and damaging the lung tissue, the body has developed a remarkable anatomical mechanism. The lungs are tightly covered by a thin inner membrane called the visceral pleura, while the inner surface of the chest wall is lined by an outer membrane called the parietal pleura.
Under normal conditions, there is a very thin layer of fluid, approximately 20 milliliters in volume, between these two membranes. This fluid functions much like machine oil, preventing friction and wear between moving parts, allowing the lungs to glide smoothly and silently within the chest cavity. The amount of fluid in this space is not static but is maintained through a continuous and dynamic cycle of production and absorption. Fresh fluid constantly filters from the tiny capillaries of the parietal pleura into the pleural space while simultaneously being reabsorbed into the bloodstream through microscopic lymphatic channels. In a healthy individual, this perfect balance between fluid production and absorption ensures that only the ideal amount of fluid remains within the pleural cavity.
What Are the Main Mechanisms That Lead to the Development of Pleural Effusion (Pleurisy)?
When the delicate balance between fluid production and absorption is disrupted for any reason, fluid begins to accumulate within the pleural space. This imbalance results from well-defined physiological and biological mechanisms. Either fluid is produced more rapidly than the lymphatic channels can absorb, or the channels responsible for removing the fluid become obstructed.
The main systemic and localized diseases that contribute to the development of pleural effusion include:
- Heart failure
- Kidney failure
- Liver cirrhosis
- Lung infections
- Lung cancer
- Tuberculosis
Each of these conditions disrupts pleural fluid balance through a different mechanism. For example, when the heart’s pumping ability weakens, increased hydrostatic pressure within blood vessels forces fluid out into the pleural space. In liver cirrhosis or severe kidney disease, blood protein levels decrease. Since proteins help retain fluid within blood vessels through oncotic pressure, reduced protein levels allow fluid to leak into the pleural cavity. In pneumonia, tuberculosis, or malignancies, the pleural membranes become inflamed and more permeable, allowing protein-rich and inflammatory fluid to accumulate. The primary goal of treatment is not only to remove the accumulated fluid but also to identify and address the underlying mechanism responsible for its formation.
What Symptoms Are Observed in Patients with Pleural Effusion (Pleurisy)?
Individuals who develop fluid accumulation between the pleural membranes begin experiencing various symptoms depending on how rapidly the fluid accumulates and its total volume. Small amounts of fluid that accumulate slowly may remain asymptomatic for months, whereas rapidly accumulating large volumes can abruptly interfere with daily life.
The most commonly encountered symptoms in clinical practice include:
- Chest pain
- Shortness of breath
- Dry cough
- Fever
- Fatigue
Chest pain is often the earliest and most bothersome symptom. Known medically as pleuritic pain, it has a highly characteristic nature. Patients experience a sharp, stabbing pain in the chest when taking a deep breath, coughing, yawning, or laughing. This pain results directly from inflammation and stretching of the parietal pleura, which contains abundant sensory nerve endings.
Shortness of breath develops because the accumulated fluid physically occupies space within the chest cavity. Since the thoracic cavity is enclosed within rigid boundaries, increasing amounts of fluid reduce the space available for lung expansion. As the lung becomes compressed, oxygen intake decreases, leading to breathlessness and a sensation of suffocation. Dry cough usually results from mechanical irritation of the airways by the fluid or inflamed pleural membranes and is generally not accompanied by sputum. Fever and fatigue are more commonly present when the underlying cause is an infection or inflammatory disease.
Which Imaging Methods Are Used to Diagnose Pleural Effusion (Pleurisy)?
After evaluating the patient’s symptoms and performing a physical examination, imaging studies are used to confirm the presence, location, quantity, and characteristics of the pleural fluid. These imaging modalities play a crucial role in guiding treatment.
The primary imaging methods used during diagnosis include:
- Chest X-ray
- Ultrasonography
- Computed tomography
A standard chest X-ray is usually the first imaging study performed. However, a certain minimum volume of fluid—approximately the equivalent of a glass of water—is generally required before the fluid becomes clearly visible. On the X-ray, the fluid accumulates in the lower chest under the influence of gravity, obscuring the normally sharp costophrenic angles with a curved white shadow.
Ultrasonography has revolutionized the diagnosis of pleural effusion by providing a radiation-free, highly practical imaging method. It can detect even minimal amounts of fluid that are invisible on chest X-rays. Ultrasound also distinguishes whether the fluid is clear or contains inflammatory debris and provides real-time guidance for safe needle insertion during thoracentesis, minimizing the risk of lung injury. Computed tomography is reserved for more complex cases, offering detailed three-dimensional visualization of lung tissue, pleural thickening, hidden tumors, and enlarged lymph nodes.
Why Is Pleural Fluid Analysis Important in the Diagnosis of Pleural Effusion (Pleurisy)?
Once imaging confirms the presence of pleural fluid, determining why it has accumulated becomes essential. For this purpose, a sample of the fluid is obtained under local anesthesia using a fine needle in a procedure called diagnostic thoracentesis.
The main laboratory parameters analyzed in pleural fluid include:
- Protein
- Glucose
- Acidity (pH)
- Lactate dehydrogenase
- Adenosine deaminase
Fluid analysis first determines whether the effusion is a transudate or an exudate, which fundamentally guides diagnosis and treatment. Transudative fluid is generally clear, watery, and low in protein content. It usually results from systemic conditions such as heart failure or kidney disease without direct pleural involvement.
Exudative fluid is cloudy, protein-rich, and contains numerous inflammatory cells. It indicates direct pleural involvement by infection, cancer, or tuberculosis. Extremely low glucose levels or high acidity within the pleural fluid indicate aggressive infection requiring prompt and complete drainage.
How Is Infected Pleural Effusion (Pleurisy) Managed?
Severe pneumonia, particularly during winter months, may spread beyond the lung tissue into the pleural space. Initially, the accumulated fluid is uncomplicated, but if appropriate antibiotic treatment is delayed, it may rapidly progress into empyema, characterized by pus accumulation within the pleural cavity. This serious condition is managed according to well-defined clinical stages.
The stages of this inflammatory process include:
- Exudative stage
- Fibrinopurulent stage
- Organizing stage
During the exudative stage, the fluid remains free-flowing and usually resolves with intravenous antibiotics alone. Once the fibrinopurulent stage develops, sticky fibrin strands divide the fluid into multiple compartments, preventing antibiotics from penetrating effectively. At this point, insertion of a chest drain or video-assisted surgical removal of the fibrous septations becomes necessary.
If treatment is delayed further, the organizing stage develops. The body forms a thick, rigid fibrous peel around the lung, trapping it and preventing expansion. At this stage, conservative treatment is no longer effective, and open surgical decortication is required to carefully remove the fibrous layer. Therefore, intervention within the first two weeks is crucial.
Which Treatments Are Used for Malignant Pleural Effusion (Pleurisy)?
One of the most serious causes of pleural effusion is the spread of cancer cells to the pleural membranes. Most commonly, primary lung cancer or metastatic cancers such as breast cancer continuously stimulate fluid production. In these situations, treatment focuses on improving quality of life while minimizing unnecessary invasive procedures.
Palliative treatment options include:
- Therapeutic thoracentesis
- Tube thoracostomy
- Chemical pleurodesis
- Tunneled pleural catheter
Patients with limited life expectancy may undergo therapeutic thoracentesis whenever shortness of breath develops. However, if fluid rapidly reaccumulates, repeated needle aspirations become burdensome. In such cases, a flexible silicone chest tube or a tunneled pleural catheter allows continuous drainage at home. If the lung re-expands completely after drainage, chemical pleurodesis may be performed to eliminate the pleural space permanently. If the lung remains trapped and cannot re-expand, tunneled pleural catheters provide long-term symptom relief while reducing hospital visits.
How Is Pleurodesis Performed in the Treatment of Pleural Effusion (Pleurisy)?
Pleurodesis is an ingenious procedure primarily used for recurrent malignant pleural effusions. The goal is to create an artificial inflammatory reaction that permanently fuses the visceral and parietal pleura together. Once the pleural layers adhere completely, there is no remaining space for fluid accumulation.
The materials used during the procedure include:
- Local anesthetic
- Pain medication
- Sterile talc powder
- Chest tube
Before the procedure, strong pain-relieving medications and local anesthetics are administered to minimize discomfort. Sterile medical-grade talc powder is then introduced into the pleural cavity. Talc induces a powerful yet controlled inflammatory response that causes the pleural surfaces to adhere.
The talc may be administered through an existing chest tube as a slurry mixed with saline or sprayed evenly over the pleural surfaces during video-assisted thoracoscopic surgery, which is considered more effective. After application, the chest tube is temporarily clamped to allow the talc to remain in contact with the pleura. Once fluid production ceases and successful adhesion occurs, the chest tube is removed. This technique effectively prevents repeated fluid accumulation and eliminates the need for frequent drainage procedures.
Which Surgical Methods Are Used to Treat Pleural Effusion (Pleurisy)?
When medical treatment is insufficient, the fluid becomes infected, accumulates rapidly, or physically compresses the lung, surgical intervention becomes necessary. Advances in technology have made these procedures significantly safer and more comfortable than in the past.
The primary surgical methods include:
- Tube thoracostomy
- Video-assisted thoracoscopic surgery
- Decortication
- Pleurectomy
Tube thoracostomy is the most frequently performed procedure. A plastic tube is inserted between the ribs under local anesthesia to drain the fluid. One important principle is that fluid surrounding a chronically collapsed lung must not be removed too rapidly, as sudden lung re-expansion may lead to re-expansion pulmonary edema. Therefore, drainage is carefully controlled.
Video-assisted thoracoscopic surgery (VATS) is a minimally invasive technique performed through one or two small incisions using high-definition cameras and specialized instruments. This approach allows surgeons to remove adhesions, obtain biopsies, and perform therapeutic interventions while enabling patients to recover much more quickly than after open surgery.
Decortication is reserved for more advanced cases and involves meticulously peeling away the thick fibrous layer restricting lung expansion. This delicate procedure resembles carefully peeling the skin from a fruit without damaging the fruit itself. Pleurectomy involves complete removal of diseased pleural tissue and is generally reserved for severe or treatment-resistant conditions.
How Does Tuberculosis-Related Pleural Effusion (Pleurisy) Progress?
Tuberculosis remains one of the most common causes of inflammatory pleural effusion in many regions. The disease often begins insidiously with mild fever, night sweats, loss of appetite, and one-sided chest pain. Pleural fluid analysis typically demonstrates a predominance of lymphocytes, indicating the body’s immune response to tuberculosis.
The diagnostic methods used include:
- Thoracentesis
- Closed pleural biopsy
- Video-assisted thoracoscopic surgery
Initial evaluation includes measurement of adenosine deaminase (ADA), an enzyme that is frequently elevated in tuberculous pleuritis. A high ADA level strongly suggests tuberculosis, although definitive diagnosis requires microscopic identification of characteristic granulomas in pleural tissue obtained through biopsy. Once diagnosed, treatment consists of prolonged anti-tuberculosis medication. Although some pleural thickening may remain after recovery, it rarely causes significant impairment or requires surgical intervention.
What Do Blood- or Lymph-Related Pleural Effusions (Pleurisy) Indicate?
The fluid accumulating within the pleural space is not always simple fluid or inflammatory exudate. Severe trauma or anatomical abnormalities may result in the accumulation of other vital body fluids.
These special clinical conditions include:
- Hemothorax
- Chylothorax
Hemothorax refers to the accumulation of fresh blood within the pleural cavity. It commonly occurs following traffic accidents, falls, or penetrating chest injuries that rupture blood vessels. This condition constitutes a medical emergency because accumulated blood rapidly clots, compressing the lung and potentially causing permanent damage. Immediate intervention is therefore essential.
Chylothorax occurs when the main lymphatic channel transporting dietary fats becomes injured, allowing milky, fat-rich lymphatic fluid to leak into the pleural space. It is often seen following major thoracic surgery or compression of lymphatic vessels by tumors. The fluid contains high triglyceride levels. Initial treatment consists of stopping oral intake and providing specialized intravenous nutrition to allow spontaneous healing. If leakage persists, surgical repair of the injured lymphatic duct or pleurodesis may be required.
Why Is Early Intervention Important in the Treatment of Pleural Effusion (Pleurisy)?
Diseases involving the pleural membranes illustrate the remarkable complexity and interconnected nature of human anatomy and physiology. Their management requires coordinated collaboration among multiple medical specialties. Correctly identifying the underlying cause helps prevent unnecessary surgery while ensuring appropriate treatment.
When pleural fluid becomes infected or blood accumulates within the chest cavity, timely intervention becomes critical. Early treatment before inflammation progresses to irreversible fibrosis allows patients to regain full lung capacity. Delayed treatment, however, may result in lifelong shortness of breath and chronic fatigue.
Thanks to modern imaging systems, minimally invasive surgical techniques, and advanced home drainage catheters, treatment has become considerably more patient-friendly. The primary objective is to evaluate disease severity, physical capacity, and life expectancy comprehensively and to provide the most effective treatment with the least possible harm at the optimal time.
Frequently Asked Questions
Prof. Dr. Alper Fındıkcıoğlu graduated from Istanbul University Faculty of Medicine and completed his thoracic surgery residency at Dr. Siyami Ersek Hospital. He began his academic career at Başkent University in 2005; he received the title of associate professor in 2014 and professor in 2022. He has extensive experience in lung cancer, chest wall diseases, and minimally invasive surgery. Since 2024, he has been continuing his professional work at Acıbadem Hospital.
